CCL2 and metabolic syndrome: Metabolic syndrome leads to a higher secretion of inflammatory mediators, such as leptin, tumor necrosis factor alpha (TNF-α), monocyte chemoattractant protein-1 (MCP-1), resistin, and interleukin 6 (IL-6) (8).